Overview

Omega 3 Fatty Acids on Serum Irisin and Sirtuin-1 in Type 2 Diabetic Mellitus Patients Treated With Glimepiride

Status:
Completed
Trial end date:
2020-05-10
Target enrollment:
0
Participant gender:
All
Summary
study the effect of omega 3 fatty acids on blood glucose, lipids profile, serum Irisin and sirtuin-1 in type 2 diabetic mellitus patients treated with glimepiride.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Damanhour University
Treatments:
Glimepiride
Criteria
Inclusion Criteria:

- 70 Adult patients aged 30-60 years old with type 2 diabetes mellitus treated with
glimepiride.

- glycated hemoglobin percent greater than 7%.

- body mass index between 25 and 35 kg/m2.

- Patients who are not consuming omega-3 fatty acids, supplements or any pharmaceutical
products that may interact with their lipid profile.

Exclusion Criteria:

- Pregnant or lactating women.

- Have gastrointestinal disorders that interfere with the bowel function

- patients with severe hepatic, renal, inflammatory and thyroid diseases.

- insulin therapy.

- Have diabetes complications including micro and macrovascular complications.

- Alcoholics and patients with past history of drug abuse.